MediPharm Labs Corp (OTCMKTS:MEDIF) Partners With Medical Cannabis by Shoppers To Supply Medical cannabis Products

MediPharm Labs Corp (OTCMKTS:MEDIF) has announced that Canada’s leading pharmacy retailer, Shoppers Drug Mart, has chosen its subsidiary MediPharm Labs Inc. as a supplier of premium cannabis concentrate products. The subsidiary will supply the products via Medical Cannabis by Shoppers platform to medical patients across Canada.

MediPharm to start the shipping of products within two months 

According to the terms of the deal, MediPharm will user its novel pharmaceutical manufacturing platform, techniques as well as scientific data to supply Medical Cannabis by Shoppers a range of cannabis concentrate products such as formulated cannabis oils.  Equally, Medipharm will provide cannabis derivatives such as topicals and gels caps once they are available.

The company will likely commence shipment of formulated cannabis oils provided for in the agreement to Shoppers within 60 days of the agreement.  The agreement will run for three years, and it is subject to renewal for another extra two years.

MediPharm positioned to provide quality products

The CEO of Medipharm Labs Pat McCutcheon indicated that they were proud to partner with a leading pharmacy retailer in Canada to supply high-quality pharmaceutical cannabis concentrates to medical consumers nationally. McCutcheon stated MediPharm has the capacity to develop premium cannabis products because of its GMP certified platform, the pharmaceutically trained team as well as research license that allows human trails. He added that their operations are backed with novel scientific research that acts as a foundation for the enhanced expansion of the company’s offerings in the future.

The Medical Cannabis by Shoppers platform launched in January last year, and it ships cannabis products directly from licensed producers to consumers across Canada. As per the current regulations in Canada, Pharmacists are not permitted to dispense medical cannabis products over the counter from a pharmacy.

Currently, there are around 1.1 million Canadians who use medical cannabis, according to Statistics Canada. Therefore MediPharm’s partnership with the pharmacy retailer is a massive opportunity for the company to supply quality medical cannabis to Canadians. This will ensure that patients who are using medical cannabis get access to the best product.

Published at Fri, 28 Feb 2020 13:42:13 +0000

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *